On 24 October 2013, Vaccines Europe held a public conference centred on the theme “Investing in Health Through Prevention: Towards Health & Growth”.
According to the recently launched European Commission Staff Working Document on ‘Investing in Health’, spending on prevention only averages 3% of overall Member State spending on healthcare in the EU27.
Prevention covers a wide-array of policies and programmes to enhance quality of life and reduce high treatment costs, from awareness raising and literacy activities to life-style related measures and vaccination programmes. Evidence suggesting the potential for improving resource allocation and cost-efficiency without increasing health spending per se is mounting and better spending at national level is determined not only by how much money is spent, but also how it is spent – which ultimately impacts health status and quality of healthcare provision.
Promoting health and growth means keeping people healthy and capable of an active societal contribution. In this regard prevention through immunisation plays an important role. This event represented an opportunity to gather public health spending analysts, health economists, public health experts, healthcare professional representatives, policy makers and industry to discuss how to make investment in health through prevention happen.
Press release and report
Opening keynote speech, Andrea RAPPAGLIOSI, President Vaccines Europe
Benefits of Adult Immunisation: a Dutch case study, Mark CONNOLLY, CEO GMAS Consultancy
Please visit our Flickr gallery